REGISTRATION RIGHTS AGREEMENT made as of June 10, 2016 by and amongRegistration Rights Agreement • September 9th, 2016 • CRISPR Therapeutics AG • Biological products, (no disgnostic substances)
WHEREAS, the Initial Holders are holders of the Company’s Preferred Shares and/or Common Shares issued upon the conversion thereof; and
SUBSCRIPTION AGREEMENTSubscription Agreement • September 9th, 2016 • CRISPR Therapeutics AG • Biological products, (no disgnostic substances)
THIS SUBSCRIPTION AGREEMENT (this “Agreement”) is made and entered into as of December 19, 2015 (the “Effective Date “), by and between CRISPR Therapeutics AG, a stock corporation (Aktiengesellschaft) organized under the laws of Switzerland and registered under the registration number CHE-494.642.722 (the “Company”), Bayer Global Investments B.V., a Dutch private company with limited liability (Besloten vennootschap met beperkte aansprakelijkheid) (“Subscriber”).
